These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32302486)
1. Ultrasound Enhances ZD2767P-Carboxypeptidase G2 against Chemoresistant Ovarian Cancer Cells by Altering the Intracellular Pharmacokinetics of ZD2767D. Liu Q; Zhong X; Zhang Y; Li X; Qian G; Yu T Mol Pharm; 2020 Jun; 17(6):1922-1932. PubMed ID: 32302486 [TBL] [Abstract][Full Text] [Related]
2. Ultrasonically Enhanced ZD2767P-Carboxypeptidase G2 Deactivates Cisplatin-Resistant Human Lung Cancer Cells. Liu Q; Li X; Luo Y; Wang H; Zhang Y; Yu T Oxid Med Cell Longev; 2022; 2022():9191233. PubMed ID: 36388164 [TBL] [Abstract][Full Text] [Related]
3. Intracellular Pharmacokinetics of Activated Drugs in a Prodrug-Enzyme-Ultrasound System: Evaluations on ZD2767P+CPG2+US. Yu T; Li X; Yu T; Chen M; Sun Y; Ran R ACS Med Chem Lett; 2024 May; 15(5):739-745. PubMed ID: 38746880 [TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue. Monks NR; Blakey DC; Curtin NJ; East SJ; Heuze A; Newell DR Br J Cancer; 2001 Sep; 85(5):764-71. PubMed ID: 11531265 [TBL] [Abstract][Full Text] [Related]
5. DNA interstrand cross-linking and TP53 status as determinants of tumour cell sensitivity in vitro to the antibody-directed enzyme prodrug therapy ZD2767. Monks NR; Blakey DC; East SJ; Dowell RI; Calvete JA; Curtin NJ; Arris CE; Newell DR Eur J Cancer; 2002 Jul; 38(11):1543-52. PubMed ID: 12110502 [TBL] [Abstract][Full Text] [Related]
6. Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material. Webley SD; Francis RJ; Pedley RB; Sharma SK; Begent RH; Hartley JA; Hochhauser D Br J Cancer; 2001 Jun; 84(12):1671-6. PubMed ID: 11401322 [TBL] [Abstract][Full Text] [Related]
7. Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2. Schepelmann S; Ogilvie LM; Hedley D; Friedlos F; Martin J; Scanlon I; Chen P; Marais R; Springer CJ Cancer Res; 2007 May; 67(10):4949-55. PubMed ID: 17510425 [TBL] [Abstract][Full Text] [Related]
8. [Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer]. Shi L; Yu H; Zhang W; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):523-30. PubMed ID: 25327735 [TBL] [Abstract][Full Text] [Related]
9. Production of Long-Acting CNGRC-CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment. Al-Mansoori L; Al Qahtani AD; Elsinga P; Goda SK Technol Cancer Res Treat; 2021; 20():15330338211057371. PubMed ID: 34802309 [No Abstract] [Full Text] [Related]
10. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482 [TBL] [Abstract][Full Text] [Related]
11. TRIAP1 Inhibition Activates the Cytochrome c/Apaf-1/Caspase-9 Signaling Pathway to Enhance Human Ovarian Cancer Sensitivity to Cisplatin. Zhang TM Chemotherapy; 2019; 64(3):119-128. PubMed ID: 31661694 [TBL] [Abstract][Full Text] [Related]
12. Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT). Monks NR; Calvete JA; Curtin NJ; Blakey DC; East SJ; Newell DR Br J Cancer; 2000 Jul; 83(2):267-9. PubMed ID: 10901381 [TBL] [Abstract][Full Text] [Related]
13. Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination. Marais R; Spooner RA; Light Y; Martin J; Springer CJ Cancer Res; 1996 Oct; 56(20):4735-42. PubMed ID: 8840992 [TBL] [Abstract][Full Text] [Related]
14. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987 [TBL] [Abstract][Full Text] [Related]
15. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related]
16. [Effect of XPG down-regulation gene expression towards the proliferation of epithelial ovarian cancer cells and its chemosensitivity to platinum]. Zhang W; Wu FX; Wang Q; Li L Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):286-91. PubMed ID: 22781116 [TBL] [Abstract][Full Text] [Related]
17. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment. Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825 [TBL] [Abstract][Full Text] [Related]
18. In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrug. Spooner RA; Martin J; Friedlos F; Marais R; Springer CJ Cancer Gene Ther; 2000 Oct; 7(10):1348-56. PubMed ID: 11059693 [TBL] [Abstract][Full Text] [Related]
19. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro]. He J; Li L; Tang BJ; Zhang W; Li DR; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):686-90. PubMed ID: 20079182 [TBL] [Abstract][Full Text] [Related]
20. Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy. Friedlos F; Lehouritis P; Ogilvie L; Hedley D; Davies L; Bermudes D; King I; Martin J; Marais R; Springer CJ Clin Cancer Res; 2008 Jul; 14(13):4259-66. PubMed ID: 18594008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]